Screener
AIM ImmunoTech AIM Q2 2026 earnings
Reported August 7, 2026 · Before market open
Revenue$26.0KMiss by $74.0K
EPS-$0.43Miss by $0.26
Revenue estimate$100.0K
EPS estimate-$0.17
Next report
Nov 16, 2026 (in 3 months)Revenue estimate$25.7K
EPS estimate-$0.12
Versus estimates
Revenue
Q2 2026$26.0KMiss by $74.0K
Q1 2026$22.0KBeat by $11.0KQ4 2025$21.0KMiss by $79.0KQ3 2025$26.0KQ2 2025$25.0KMiss by $75.0KQ1 2025$16.0KDiluted EPS
FAQ
- When did AIM ImmunoTech report Q2 2026 earnings?
- AIM ImmunoTech (AIM) reported Q2 2026 earnings on August 7, 2026 before market open.
- What were AIM ImmunoTech's Q2 2026 revenue and EPS?
- AIM ImmunoTech reported revenue of $26.0K and eps of $-0.43 for Q2 2026.
- Did AIM ImmunoTech beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $100.0K by $74.0K. EPS missed the consensus estimate of $-0.17 by $0.26.
- How did AIM ImmunoTech's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 4.0% from $25.0K a year earlier and eps grew 88.3% from $-3.68.
- Where can I find AIM ImmunoTech's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001493152-26-036104) and the 10-Q periodic report (0001493152-26-036609) directly on SEC EDGAR. The filing index links above go to sec.gov.
